Fundraising FoxHealthtech Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery.
HardwareHealthtechMedical DevicesSaint Michael, US
Thierry Thaure(CEO & Co-founder)inMichel Gagner(CMO & Co-founder)in
Co-investorsKrillion Ventures
A biotech company developing Microbiota Transplant Therapy (MTT), a patented treatment that restructures the gut microbiome to improve symptoms of Autism Spectrum Disorder and Pitt-Hopkins Syndrome.
BiotechHealthtechTempe, US
Rosa Krajalnik-Brown(Director)Alexander Khoruts(Director)James B. Adams(Executive Officer, Director)Michael J. Sadowsky(Director)Rosa Krajmalnik-Brown(Director)inAlexander Khorus(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.